John Overdeck’s ARK Genomic Revolution ETF ARKG Stock Holding History

John Overdeck’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-47,800	Closed	-$1.26M	–	5052
2026 Q1	$1.26M	Sell	47,800 -169,900	-78%	-$4.98M	﹤0.01%	3081
2025 Q4	$6.31M	Buy	217,700 +190,300	+695%	+$5.71M	0.01%	1504
2025 Q3	$761K	Sell	27,400 -97,800	-78%	-$2.47M	﹤0.01%	2756
2025 Q2	$3.05M	Buy	+125,200	New	+$2.74M	0.01%	1548
2025 Q1	–	Sell	-961,500	Closed	-$22.6M	–	3192
2024 Q4	$22.6M	Buy	961,500 +829,200	+627%	+$20.4M	0.05%	440
2024 Q3	$3.39M	Buy	132,300 +14,100	+12%	+$359K	0.01%	1311
2024 Q2	$2.78M	Sell	118,200 -98,600	-45%	-$2.49M	0.01%	1333
2024 Q1	$6.24M	Sell	216,800 -217,500	-50%	-$6.54M	0.01%	858
2023 Q4	$14.2M	Buy	+434,300	New	+$11.8M	0.03%	537
2023 Q2	–	Sell	-20,800	Closed	-$625K	–	2995
2023 Q1	$625K	Buy	+20,800	New	+$645K	﹤0.01%	2102

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

John Overdeck's ARKG Position: Q2 2026 in Review

John Overdeck sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 47,800 shares — an estimated $1.26M sold.

John Overdeck first reported a position in ARKG in Q1 2023 and held it in 10 quarters. The position peaked at $22.6M in Q4 2024. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

John Overdeck reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
John Overdeck sold 47,800 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $1.26M.
John Overdeck first reported a position in ARK Genomic Revolution ETF in Q1 2023 and held it in 10 quarters.
John Overdeck's ARK Genomic Revolution ETF position peaked at $22.6M in Q4 2024.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.